Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2007 Jun;7(6):429-40.

The cofilin pathway in breast cancer invasion and metastasis.

Author information

1
Experimental Therapeutics, ImClone Systems Incorporated, New York, New York, USA.

Abstract

Recent evidence indicates that metastatic capacity is an inherent feature of breast tumours and not a rare, late acquired event. This has led to new models of metastasis. The interpretation of expression-profiling data in the context of these new models has identified the cofilin pathway as a major determinant of metastasis. Recent studies indicate that the overall activity of the cofilin pathway, and not that of any single gene within the pathway, determines the invasive and metastatic phenotype of tumour cells. These results predict that inhibitors directed at the output of the cofilin pathway will have therapeutic benefit in combating metastasis.

PMID:
17522712
PMCID:
PMC4270061
DOI:
10.1038/nrc2148
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center